title: Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma.
abstract: The transcription factor, nuclear factor kappaB (NF-kappaB), plays a central role as a key mediator of cell survival and proliferation, and its activation may confer increased tumor chemoresistance. Curcumin, an orally available naturally occurring compound, has been shown to inhibit NF-kappaB and has a potential role in cancer chemoprevention. We investigated the effects of curcumin on NF-kappaB activity, on cell viability, and as a chemosensitizing agent with 5-fluorouracil (5-FU) or cisplatin (CDDP) in esophageal adenocarcinoma (EAC). Oligonucleotide microarray analysis of 46 cases, consisting of Barrett metaplasia, low-grade dysplasia, high-grade dysplasia and EAC, showed increased expression of NF-kappaB and IkappaB kinase subunits and decreased effector caspase expression in EAC compared with Barrett metaplasia. Stromal expression of both IkappaB and phospho-IkappaB was detected in several EAC samples by tissue microarray analysis. Curcumin alone inhibited NF-kappaB activity and induced apoptosis in both Flo-1 and OE33 EAC cell lines as determined by Western blot analysis, NF-kappaB reporter assays, and Caspase-Glo 3/7 assays. It also increased 5-FU- and CDDP-induced apoptosis in both cell lines. These data suggest that activation of NF-kappaB and inhibition of apoptosis may play a role in the progression from Barrett metaplasia to EAC. In addition, curcumin, a well-known inhibitor of NF-kappaB activity, was shown to increase apoptosis and enhance both 5-FU- and CDDP-mediated chemosensitivity, suggesting that it may have potential application in the therapy of patients with EAC.
authors.affiliation: Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
authors.forename: Wibisono
authors.initials: W
authors.lastname: Hartojo
authors.forename: Amy L
authors.initials: AL
authors.lastname: Silvers
authors.forename: Dafydd G
authors.initials: DG
authors.lastname: Thomas
authors.forename: Christopher W
authors.initials: CW
authors.lastname: Seder
authors.forename: Lin
authors.initials: L
authors.lastname: Lin
authors.forename: Hyma
authors.initials: H
authors.lastname: Rao
authors.forename: Zhuwen
authors.initials: Z
authors.lastname: Wang
authors.forename: Joel K
authors.initials: JK
authors.lastname: Greenson
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Giordano
authors.forename: Mark B
authors.initials: MB
authors.lastname: Orringer
authors.forename: Alnawaz
authors.initials: A
authors.lastname: Rehemtulla
authors.forename: Mahaveer S
authors.initials: MS
authors.lastname: Bhojani
authors.forename: David G
authors.initials: DG
authors.lastname: Beer
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Chang